Company

Aldeyra Therapeutics, Inc. (ALDX)

Standardized SEC financial data for Aldeyra Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001341235 · NASDAQ · Pharmaceutical Preparations.

Return on equity

-76.5%

ROIC

-585.4%

Free cash flow

-$33.3M

Debt / equity

0.69×

Current ratio

2.58×

EPS (diluted)

$-0.56

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
R&D expense	$24.7M	$44.9M	$47.3M	$29.5M	$48.2M	$25.7M
SG&A expense	$10.0M	$11.3M	$15.4M	$13.3M	$11.9M	$9.6M
Operating income	-$36.4M	-$56.2M	-$62.7M	-$42.8M

Standardized from Aldeyra Therapeutics, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$77.9M	$229.8M	$144.4M	$142.8M	$54.5M	$70.0M
Total current assets	$83.1M	$232.8M	$181.0M	$147.8M	$104.1M	$71.8M
Property, plant & equipment	$60K	$32K	$19K	$6K

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$37.5M	-$42.6M	-$56.6M	-$30.3M	-$43.2M	-$33.3M
Capital expenditures	—	$8K	$16K	$0	—	—
Free cash flow	—	-$42.6M	-$56.7M	-$30.3M	—

Get ALDX data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ALDX/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ALDX/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View ALDX filings on SEC EDGAR →